129 related articles for article (PubMed ID: 19951251)
21. Human Neural Stem Cells Overexpressing a Carboxylesterase Inhibit Bladder Tumor Growth.
Choi SS; Chi BH; Chang IH; Kim KD; Lee SR; Kim SU; Lee HJ
Mol Cancer Ther; 2016 Jun; 15(6):1201-7. PubMed ID: 27009215
[TBL] [Abstract][Full Text] [Related]
22. The in vitro metabolism of irinotecan (CPT-11) by carboxylesterase and beta-glucuronidase in human colorectal tumours.
Tobin P; Clarke S; Seale JP; Lee S; Solomon M; Aulds S; Crawford M; Gallagher J; Eyers T; Rivory L
Br J Clin Pharmacol; 2006 Jul; 62(1):122-9. PubMed ID: 16842384
[TBL] [Abstract][Full Text] [Related]
23. Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression.
Kim SK; Kim SU; Park IH; Bang JH; Aboody KS; Wang KC; Cho BK; Kim M; Menon LG; Black PM; Carroll RS
Clin Cancer Res; 2006 Sep; 12(18):5550-6. PubMed ID: 17000692
[TBL] [Abstract][Full Text] [Related]
24. Tumor targeting carboxylesterase fused with anti-CEA scFv improve the anticancer effect with a less toxic dose of irinotecan.
Uchino J; Takayama K; Harada A; Sone T; Harada T; Curiel DT; Kuroki M; Nakanishi Y
Cancer Gene Ther; 2008 Feb; 15(2):94-100. PubMed ID: 18157147
[TBL] [Abstract][Full Text] [Related]
25. Conversion of the CPT-11 metabolite APC to SN-38 by rabbit liver carboxylesterase.
Guichard SM; Morton CL; Krull EJ; Stewart CF; Danks MK; Potter PM
Clin Cancer Res; 1998 Dec; 4(12):3089-94. PubMed ID: 9865925
[TBL] [Abstract][Full Text] [Related]
26. Isolation and partial characterization of a cDNA encoding a rabbit liver carboxylesterase that activates the prodrug irinotecan (CPT-11).
Potter PM; Pawlik CA; Morton CL; Naeve CW; Danks MK
Cancer Res; 1998 Jun; 58(12):2646-51. PubMed ID: 9635592
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of a rabbit liver carboxylesterase sensitizes human tumor cells to CPT-11.
Danks MK; Morton CL; Pawlik CA; Potter PM
Cancer Res; 1998 Jan; 58(1):20-2. PubMed ID: 9426050
[TBL] [Abstract][Full Text] [Related]
28. Optimization of a Neural Stem-Cell-Mediated Carboxylesterase/Irinotecan Gene Therapy for Metastatic Neuroblastoma.
Gutova M; Goldstein L; Metz M; Hovsepyan A; Tsurkan LG; Tirughana R; Tsaturyan L; Annala AJ; Synold TW; Wan Z; Seeger R; Anderson C; Moats RA; Potter PM; Aboody KS
Mol Ther Oncolytics; 2017 Mar; 4():67-76. PubMed ID: 28345025
[TBL] [Abstract][Full Text] [Related]
29. Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells.
Lee DH; Ahn Y; Kim SU; Wang KC; Cho BK; Phi JH; Park IH; Black PM; Carroll RS; Lee J; Kim SK
Clin Cancer Res; 2009 Aug; 15(15):4925-34. PubMed ID: 19638465
[TBL] [Abstract][Full Text] [Related]
30. Characterization of inhibitors of specific carboxylesterases: development of carboxylesterase inhibitors for translational application.
Yoon KJ; Hyatt JL; Morton CL; Lee RE; Potter PM; Danks MK
Mol Cancer Ther; 2004 Aug; 3(8):903-9. PubMed ID: 15299073
[TBL] [Abstract][Full Text] [Related]
31. Identification and activities of human carboxylesterases for the activation of CPT-11, a clinically approved anticancer drug.
Senter PD; Beam KS; Mixan B; Wahl AF
Bioconjug Chem; 2001; 12(6):1074-80. PubMed ID: 11716702
[TBL] [Abstract][Full Text] [Related]
32. Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2.
Humerickhouse R; Lohrbach K; Li L; Bosron WF; Dolan ME
Cancer Res; 2000 Mar; 60(5):1189-92. PubMed ID: 10728672
[TBL] [Abstract][Full Text] [Related]
33. Double suicide gene therapy using human neural stem cells against glioblastoma: double safety measures.
Lee JY; Lee DH; Kim HA; Choi SA; Lee HJ; Park CK; Phi JH; Wang KC; Kim SU; Kim SK
J Neurooncol; 2014 Jan; 116(1):49-57. PubMed ID: 24113876
[TBL] [Abstract][Full Text] [Related]
34. Development of an etoposide prodrug for dual prodrug-enzyme antitumor therapy.
Yoon KJ; Qi J; Remack JS; Virga KG; Hatfield MJ; Potter PM; Lee RE; Danks MK
Mol Cancer Ther; 2006 Jun; 5(6):1577-84. PubMed ID: 16818517
[TBL] [Abstract][Full Text] [Related]
35. Sensitization of human tumor cells to CPT-11 via adenoviral-mediated delivery of a rabbit liver carboxylesterase.
Wierdl M; Morton CL; Weeks JK; Danks MK; Harris LC; Potter PM
Cancer Res; 2001 Jul; 61(13):5078-82. PubMed ID: 11431344
[TBL] [Abstract][Full Text] [Related]
36. Effect of carboxylesterase inhibition on the anti-tumour effects of irinotecan.
Morishita Y; Fujii M; Kasakura Y; Takayama T
J Int Med Res; 2005; 33(1):84-9. PubMed ID: 15651719
[TBL] [Abstract][Full Text] [Related]
37. Adenoviral vector-mediated expression of a gene encoding secreted, EpCAM-targeted carboxylesterase-2 sensitises colon cancer spheroids to CPT-11.
Oosterhoff D; Overmeer RM; de Graaf M; van der Meulen IH; Giaccone G; van Beusechem VW; Haisma HJ; Pinedo HM; Gerritsen WR
Br J Cancer; 2005 Mar; 92(5):882-7. PubMed ID: 15756257
[TBL] [Abstract][Full Text] [Related]
38. A Potential Therapy Using Engineered Stem Cells Prevented Malignant Melanoma in Cellular and Xenograft Mouse Models.
Heo JR; Hwang KA; Kim SU; Choi KC
Cancer Res Treat; 2019 Apr; 51(2):797-811. PubMed ID: 30213181
[TBL] [Abstract][Full Text] [Related]
39. Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin.
Brown AB; Yang W; Schmidt NO; Carroll R; Leishear KK; Rainov NG; Black PM; Breakefield XO; Aboody KS
Hum Gene Ther; 2003 Dec; 14(18):1777-85. PubMed ID: 14670128
[TBL] [Abstract][Full Text] [Related]
40. Human adipose tissue-derived mesenchymal stem cells: characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas.
Choi SA; Lee JY; Wang KC; Phi JH; Song SH; Song J; Kim SK
Eur J Cancer; 2012 Jan; 48(1):129-37. PubMed ID: 21664124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]